| Name | Title | Contact Details |
|---|---|---|
Paul Nendick |
Chief Technology Officer | Profile |
GCG Communications is a Reston, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Oral Health Products is a Tulsa, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Amway is the world`s No. 1 direct selling business, according to the Direct Selling News Global 100. Established in 1959, with sales of $8.6 billion, Amway operates in more than 100 countries and territories. We manufacture and distribute 450+ consumer products that support health and well-being. More than 19,000 employees worldwide support millions of Amway Business Owners who sell Amway products. Headquartered in Ada, Michigan, Amway is a center of health, skincare and home product innovation and top-selling, global brands. In addition, we are a company committed to providing employees with challenging career opportunities, a comprehensive total rewards package, profit sharing, tuition assistance, product discounts and an award-winning wellness program.
Neuralstem is a dual platform regenerative medicine company. The company`s technology enables the production of regionally specific, physiologically relevant neural stem cells for therapeutic use for the treatment of central nervous system (CNS) diseases and has enabled the discovery of a library of patented small molecule neurogenic compounds to treat psychological and cognitive disorders. Neuralstem`s small molecule drug discovery program screens human neural stem cell lines for compounds that may stimulate neurogenesis in the brain, possibly reversing pathologies associated with certain CNS conditions. The company`s lead compound, NSI-189, has completed FDA Phase Ia and Ib safety trials for the treatment of major depressive disorder (MDD). Neuralstem is expecting to launch a Phase II study for MDD in 2015. Neuralstem`s first stem cell therapy product, NSI-566, a spinal cord-derived neural stem cell line, is in ongoing clinical trials to treat amyotrophic lateral sclerosis (ALS, or Lou Gehrig`s disease), for which it has received orphan status designation by the FDA. Dosing in a phase IIa trial was completed in July, 2014. The next trial is anticipated to commence in 2015. In addition to ALS, the company is conducting an NSI-566 Phase I trial in chronic spinal cord injury, with NSI-566 clinical development also underway to treat ischemic
digiChart Announces New Executives and New Offices July 15, 2010 BRENTWOOD, Tenn.--(BUSINESS WIRE)--digiChart, Inc. today announced the appointment of two new members to its executive team, Bob Allen and Stephen Faris. The company also announced the relocation of its headquarters to Brentwood, TN, a nearby suburb of Nashville, TN. Bob Allen joins digiChart as National Director of Sales. Mr. Allen will be responsible for all the sales and marketing efforts of the company. Most recently, he served as Vice President of Sales in McKessons Physician Practice Solutions business. He brings over 20 years experience in sales and healthcare technology. Stephen Faris will serve as Vice President of Technology, leading digiCharts product development and technical operations. He previously served as Chief Technology Officer for Healthgate Data Corporation and has extensive experience consulting with companies on their technology and applications strategies. We are excited two exceptional leaders such as Bob and Stephen join our executive team, said digiChart CEO Bill Bates. We are growing and moving forward with exciting initiatives to fully connect OB-GYN care. Bob and Stephens experience will serve us well. They will be central to our success. digiChart also announced the relocation of its headquarters to Brentwood, TN, a nearby suburb of Nashville, TN. The move positions the leader in OB-GYN electronic medical records and practice management systems software for its growth plans and will enable improved service and support for its customers throughout the United States. The Nashville area is a hub for the healthcare, said COO Shelley Predmore. We have enjoyed a rewarding history of growth and success from being in the center of the industrys activities and will continue to do so. Our new offices offer us a state-of-the-art training center for our clients and better consolidate our overall operations. The space will serve us for years to come as we serve our customers. The companys new address is: digiChart, Inc. 100 Winner's Circle, Suite 450 Brentwood, TN 37027 About digiChart, Inc. (www.digichart.com) Based in Brentwood, TN, digiChart, Inc. is a leader in healthcare information technology solutions and services. Dedicated to improving women's healthcare, digiChart provides electronic health record (EHR) and practice management system (PMS) solutions, along with the related training, implementation and workflow improvement services. OB-GYN practices across the country use digiChart's solutions to streamline and optimize their practices clinically and inancially, as well as achieve higher rates of patient satisfaction. Every day, over 100,000 active pregnancies and nearly 1,800,000 womens records are managed through digiCharts solutions. digiChart is a MedCare company. MedCare is a althcare-focused fund invested in a portfolio of healthcare services, healthcare IT and medical device companies with combined revenues of over $350M. Contacts digiChart, Inc. Shelley Predmore, Chief Operating Officer, 615-312-1630 ore@digichart.com